seeland.ch

2 Einträge von 2 mit initiated study

www.green.ch

Datum der Indexierung 05.05.2024 02:54:55
erkannte Namen Robert Süess |
Subdomain:
extern (outbound) Link/Domain 5 in www.green.ch
intern (inbound) Link/Domain www.green.ch
Alle Links in alle Links in www.green.ch
HTML Description Simply register domain for website Order hosting too and benefit from 50% promo .ch How do I secure the domain I want?
Kombination Keywords domain telephony | hosting register | your name | website business | internet solutions | green email | security with | data cloud | swiss offer | center year |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
initiated the payment. Activating a .ch or .com domain takes the shortest amount of time – around four hours in each case. We will notify you as soon as the domain has been registered and will send you your personal control panel login details by ema Study GDI Blockchain Study Partner Login Support Career Contact en de en Get the right domain for your website now Get the right domain for your website now www. Search domain Simply register domain for website Is your desired dom
Text Inhalt Text aus URL
Log Metriken 47071
URL /en/sme/website-domain/register

www.cslbehring.ch

Datum der Indexierung 04.10.2024 23:31:04
erkannte Namen Gene Therapy | Emmanuelle Lecomte | Isabelle Dahinden | Maria Tortoreto | Asia Pacific |
weitere Namen in www.cslbehring.ch 5
Subdomain:
extern (outbound) Link/Domain 8 in www.cslbehring.ch
intern (inbound) Link/Domain www.cslbehring.ch
Alle Links in alle Links in www.cslbehring.ch
HTML Description Swissmedic Approval for HEMGENIX®
Kombination Keywords patients rare | hemgenix this | factor from | hemophilia people | with gene | treatment disease | that therapy | behring your | bleeding more | switzerland global |
Alle Keywords (Suchwörter) Liste aller Einträge
Textauszug aus Quelle
Initiated Studies We operate as one integrated global R&D organization that assembles coordinated global project teams. R&D at a Glance CSL supports Investigator-Initiated Studies (IIS) that advance medical and scientific knowledge of CSL Behring pro study to evaluate the safety and efficacy of HEMGENIX®. Fifty-four adult hemophilia B patients classified as having moderately severe to severe hemophilia B and requiring prophylactic factor IX replacement therapy were enrolled in
Text Inhalt Text aus URL
Log Metriken 86111
URL /en-us/news/2024/approval-hemgenix

Menu

  • Home
  • Dokumente
  • Namen
  • Keywords (Text)
  • Links
  • Domain
  • externe links
  • interne links
  • Subdomain
  • Statistik
  • Impressum